Non-reimbursable analgesics or painkillers

Chronic pain patients are entitled to reimbursement for paracetamol-based painkillers.

They only pay a limited personal share instead of the full amount for these analgesics (paracetamol-based painkillers).

Important :

The introduction of reimbursement is part of the specific protection measures for the chronically ill.
The reimbursement does not apply to hospitalized patients and to patients admitted to a psychiatric care home.
The amount charged to the patient is counted as a personal share towards the maximum bill (MAF).

What are the conditions?

The patient suffers from a well-defined condition :
- cancer pain;
- chronic arthritis/osteoarthritis pain;
- neurogenic or neuropathic pain of central or peripheral origin (including multiple sclerosis);
- peripheral vascular pain;
- post-surgical pain (including phantom limb pain);
- fibromyalgia.
The pain :
- persists for at least three months after optimal curative treatment;
- persists after curative treatment of a clinical picture of malignant chronic pain.
The analgesic is eligible for reimbursement.

Request from the consulting physician
The treating physician or the physician who manages the global medical file submits a request based on Chapter IV § 5460000 to the CM's consulting physician.
Receipt of authorization
After approval by the advising doctor, the patient receives an authorization that is valid for life.
Awarding reimbursement
When purchasing the medicine, the pharmacist will immediately settle the reimbursement upon presentation of:
- the electronic identity card (eID) or ISI+ card;
- a prescription.